A prospective randomized trial for the comparison of two BCG strains (Bacille Calmette-Guerin) in the prophylaxis of papillary bladder tumors stage Ta and T1 and treatment of carcinoma in situ.

Trial Profile

A prospective randomized trial for the comparison of two BCG strains (Bacille Calmette-Guerin) in the prophylaxis of papillary bladder tumors stage Ta and T1 and treatment of carcinoma in situ.

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Jul 2012

At a glance

  • Drugs BCG (Primary) ; BCG (Primary)
  • Indications Bladder cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 May 2012 5-year results presented at the 107th Annual Meeting of the American Urological Association.
    • 30 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Mar 2012 Actual end date (1 Jun 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top